NCT07438184

Brief Summary

This randomized controlled clinical trial evaluates the impact of non-surgical periodontal therapy on systemic inflammatory markers in patients with chronic prostatitis or recurrent urinary tract infections. Emerging evidence suggests a possible association between periodontal inflammation and genitourinary conditions. A total of 60 male participants diagnosed with periodontitis and either chronic prostatitis or recurrent urinary tract infections were randomly assigned to one of three groups: non-surgical periodontal therapy, oral hygiene instruction only, or no periodontal treatment. The primary outcomes were changes in serum prostate-specific antigen (PSA) levels and the frequency of positive urine cultures over a 120-day follow-up period. The study aims to investigate whether periodontal treatment may reduce systemic inflammatory burden and improve genitourinary clinical parameters.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2024

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2025

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

February 22, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 27, 2026

Completed
Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

February 22, 2026

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in serum prostate-specific antigen (PSA) levels

    Difference in serum prostate-specific antigen (PSA) levels measured in ng/mL between baseline and 120 days after intervention.

    Baseline to 120 days

Secondary Outcomes (1)

  • Change in frequency of positive urine cultures

    Baseline to 120 days

Study Arms (3)

Non-Surgical Periodontal Therapy

EXPERIMENTAL

Participants received full-mouth scaling and root planing combined with oral hygiene instruction.

Procedure: Non-surgical periodontal therapy

Oral Hygiene Instruction

ACTIVE COMPARATOR

Participants received standardized oral hygiene instructions without mechanical periodontal treatment.

Behavioral: Oral hygiene instruction

Control

NO INTERVENTION

Participants did not receive periodontal treatment during the 120-day follow-up period.

Interventions

Full-mouth scaling and root planing performed under local anesthesia using ultrasonic and hand instruments, completed within two sessions over a one-week period. Participants also received standardized oral hygiene instructions including tooth brushing technique and interdental cleaning guidance.

Non-Surgical Periodontal Therapy

Standardized oral hygiene instructions including tooth brushing technique, use of interdental cleaning devices, and reinforcement of plaque control measures, without mechanical periodontal instrumentation.

Oral Hygiene Instruction

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male participants aged 18 years or older
  • Diagnosis of chronic prostatitis (NIH category III) or recurrent urinary tract infections
  • Diagnosis of periodontitis according to the 2017 World Workshop classification
  • Ability to provide written informed consent

You may not qualify if:

  • Antibiotic therapy within the previous 3 months
  • Systemic immunosuppressive disorders
  • History of prostate cancer
  • Ongoing periodontal treatment
  • Severe systemic diseases affecting inflammatory status

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Salamanca

Salamanca, Spain

Location

MeSH Terms

Conditions

PeriodontitisUrinary Tract Infections

Condition Hierarchy (Ancestors)

Periodontal DiseasesMouth DiseasesStomatognathic DiseasesInfectionsUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention, blinding of participants and care providers was not feasible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomly assigned in a parallel design to one of three groups: non-surgical periodontal therapy, oral hygiene instruction, or no periodontal treatment, with a 120-day follow-up period.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Department

Study Record Dates

First Submitted

February 22, 2026

First Posted

February 27, 2026

Study Start

January 1, 2024

Primary Completion

April 1, 2025

Study Completion

April 1, 2025

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations